Uromune in Treating Recurrent Urinary Tract Infections in Women

Summary

To determine the effectiveness and safety of the vaccine Uromune in Canadian women with recurrent urinary tract infection.

Timeline

Start

2019-09-06

Primary completion

2022-10-31

Completion

2023-01-01

Outcome

Outcome not reported

Stopped (Business): “Convenience sample based on available funding. Increased Covid-related costs of clinical research resulted in early termination”

Drugs

Indications